Questions for Exam 2012
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Long-Term Potentiation Differentially Affects Two Components of Synaptic
Proc. Nati. Acad. Sci. USA Vol. 85, pp. 9346-9350, December 1988 Neurobiology Long-term potentiation differentially affects two components of synaptic responses in hippocampus (plasticity/N-methyl-D-aspartate/D-2-amino-5-phosphonovglerate/facilitation) DOMINIQUE MULLER*t AND GARY LYNCH Center for the Neurobiology of Learning and Memory, University of California, Irvine, CA 92717 Communicated by Leon N Cooper, September 6, 1988 (receivedfor review June 20, 1988) ABSTRACT We have used low magnesium concentrations ing electrode was positioned in field CAlb between two and the specific antagonist D-2-amino-5-phosphonopentanoate stimulating electrodes placed in fields CAla and CAlc; this (D-AP5) to estimate the effects of long-term potentiation (LTP) allowed us to activate separate inputs to a common pool of on the N-methyl-D-aspartate (NMDA) and non-NMDA recep- target cells. Stimulation voltages were adjusted to produce tor-mediated components of postsynaptic responses. LTP in- field EPSPs of -1.5 mV and did not elicit population spikes duction resulted in a considerably larger potentiation of non- in any of the responses included for data analysis. NMDA as opposed to NMDA receptor-related currents. In- Paired-pulse facilitation was produced by applying two creasing the size of postsynaptic potentials with greater stimulation pulses separated by 30 or 50 ms to the same stimulation currents or with paired-pulse facilitation produced stimulating electrode and LTP was induced by patterned opposite effects; i.e., those aspects ofthe response dependent on burst stimulation-i.e., 10 bursts delivered at 5 Hz, each NMDA receptor's increased to a greater degree than did those burst being composed of four pulses at 100 Hz (see ref. -
(Ssris) SEROTONIN and NOREPHINEPHRINE REUPTAKE INHIBITORS DOPAMINE and NOREPINEPHRINE RE
VA / DOD DEPRESSION PRACTICE GUIDELINE PROVIDER CARE CARD ANTIDEPRESSANT MEDICATION TABLE CARD 7 Refer to pharmaceutical manufacturer’s literature for full prescribing information SEROTONIN SELECTIVE REUPTAKE INHIBITORS (SSRIs) GENERIC BRAND NAME ADULT STARTING DOSE MAX EXCEPTION SAFETY MARGIN TOLERABILITY EFFICACY SIMPLICITY Citalopram Celexa 20 mg 60 mg Reduce dose Nausea, insomnia, Fluoxetine Prozac 20 mg 80 mg for the elderly & No serious systemic sedation, those with renal toxicity even after headache, fatigue Paroxetine Paxil 20 mg 50 mg or hepatic substantial overdose. dizziness, sexual AM daily dosing. failure Drug interactions may dysfunction Response rate = Can be started at Sertraline Zoloft 50 mg 200 mg include tricyclic anorexia, weight 2 - 4 wks an effective dose First Line Antidepressant Medication antidepressants, loss, sweating, GI immediately. Drugs of this class differ substantially in safety, tolerability and simplicity when used in patients carbamazepine & distress, tremor, warfarin. restlessness, on other medications. Can work in TCA (tricyclic antidepressant) nonresponders. Useful in agitation, anxiety. several anxiety disorders. Taper gradually when discontinuing these medications. SEROTONIN and NOREPHINEPHRINE REUPTAKE INHIBITORS GENERIC BRAND NAME ADULT STARTING DOSE MAX EXCEPTION SAFETY MARGIN TOLERABILITY EFFICACY SIMPLICITY Reduce dose Take with food. Venlafaxine IR Effexor IR 75 mg 375 mg Comparable to BID or TID for the elderly & No serious systemic SSRIs at low dose. dosing with IR. those with renal toxicity. Nausea, dry mouth, Response rate = Daily dosing or hepatic Downtaper slowly to Venlafaxine XR Effexor XR 75 mg 375 mg insomnia, anxiety, 2 - 4 wks with XR. failure prevent clinically somnolence, head- (4 - 7 days at Can be started at significant withdrawal ache, dizziness, ~300 mg/day) an effective dose Dual action drug that predominantly acts like a Serotonin Selective Reuptake inhibitor at low syndrome. -
Neurophysiology of Frog Dorsal Root Afferent Fibers and Their Intraspinal Processes
Loyola University Chicago Loyola eCommons Dissertations Theses and Dissertations 1989 Neurophysiology of Frog Dorsal Root Afferent Fibers and Their Intraspinal Processes Nancy C. Tkacs Loyola University Chicago Follow this and additional works at: https://ecommons.luc.edu/luc_diss Part of the Physiology Commons Recommended Citation Tkacs, Nancy C., "Neurophysiology of Frog Dorsal Root Afferent Fibers and Their Intraspinal Processes" (1989). Dissertations. 2652. https://ecommons.luc.edu/luc_diss/2652 This Dissertation is brought to you for free and open access by the Theses and Dissertations at Loyola eCommons. It has been accepted for inclusion in Dissertations by an authorized administrator of Loyola eCommons. For more information, please contact [email protected]. This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License. Copyright © 1989 Nancy C. Tkacs UBRA~Y·· NEUROPHYSIOLOGY OF FROG DORSAL ROOT AFFERENT FIBERS AND THEIR INTRASPINAL PROCESSES by Nancy C. Tkacs A Dissertation Submitted to the Faculty of the Graduate School of .Loyola University of Chicago in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy April 1989 DEDICATION To Bill, with deep love and gratitude ii ACKNOWLEDG.EMENTS I would like to thank the faculty of the Department of Physiology for the excellent training I have received. I am particularly grateful to Dr. James Filkins for supporting my dissertation research. My thanks also go to Dr. Charles Webber, Dr. David Euler, Dr. David Carpenter, and Dr. Sarah Shefner for serving on my dissertation committee. Their helpful suggestions added much to the research and the dissertation. My gratitude goes to several individuals who unselfishly shared their time, resources, and expertise. -
Action Potential and Synapses
SENSORY RECEPTORS RECEPTORS GATEWAY TO THE PERCEPTION AND SENSATION Registering of inputs, coding, integration and adequate response PROPERTIES OF THE SENSORY SYSTEM According the type of the stimulus: According to function: MECHANORECEPTORS Telereceptors CHEMORECEPTORS Exteroreceptors THERMORECEPTORS Proprioreceptors PHOTORECEPTORS interoreceptors NOCICEPTORS STIMULUS Reception Receptor – modified nerve or epithelial cell responsive to changes in external or internal environment with the ability to code these changes as electrical potentials Adequate stimulus – stimulus to which the receptor has lowest threshold – maximum sensitivity Transduction – transformation of the stimulus to membrane potential – to generator potential– to action potential Transmission – stimulus energies are transported to CNS in the form of action potentials Integration – sensory information is transported to CNS as frequency code (quantity of the stimulus, quantity of environmental changes) •Sensation is the awareness of changes in the internal and external environment •Perception is the conscious interpretation of those stimuli CLASSIFICATION OF RECEPTORS - adaptation NONADAPTING RECEPTORS WITH CONSTANT FIRING BY CONSTANT STIMULUS NONADAPTING – PAIN TONIC – SLOWLY ADAPTING With decrease of firing (AP frequency) by constant stimulus PHASIC– RAPIDLY ADAPTING With rapid decrease of firing (AP frequency) by constant stimulus ACCOMODATION – ADAPTATION CHARACTERISTICS OF PHASIC RECEPTORS ALTERATIONS OF THE MEMBRANE POTENTIAL ACTION POTENTIAL TRANSMEMBRANE POTENTIAL -
Fast and Slow Synaptic Potentials Produced Ina Mammalian
Proc. Nat!. Acad. Sci. USA Vol. 83, pp. 1941-1944, March 1986 Neurobiology Fast and slow synaptic potentials produced in a mammalian sympathetic ganglion by colon distension (visceral afferent/inferior mesenteric ganglion/noncholinergic) STEPHEN PETERS AND DAVID L. KREULEN Department of Pharmacology, University of Arizona Health Sciences Center, Tucson, AZ 85724 Communicated by C. Ladd Prosser, November 1, 1985 ABSTRACT Radial distension of the large intestine pro- way also comprises noncholinergic fibers; indeed, it remains duced a slow depolarization in a population of neurons in the to be determined whether noncholinergic slow EPSPs even inferior mesenteric ganglion of the guinea pig. The slow occur physiologically. potentials often occurred simultaneously with cholinergic fast We report here the discovery of a noncholinergic sensory potentials [(excitatory postsynaptic potentials (EPSPs)] yet pathway that projects from the distal colon to the inferior persisted in the presence of nicotinic and muscarinic choliner- mesenteric ganglion (1MG) of the guinea pig. This pathway, gic antagonists when all fast EPSPs were absent. The amplitude activated by colon distension, produces noncholinergic slow of the distension-induced noncholinergic slow depolarization depolarizations resembling nerve-evoked slow EPSPs in increased with increasing distension pressure. For distensions sympathetic ganglion cells. Often, distension of the colon of 1-min duration at pressures of 10-20 cm of water, the mean produced both an increase in cholinergic EPSPs and a slow depolarization amplitude was 3.4 mV. The slow depolarization depolarization, suggesting a simultaneous action of two was associated with an increase in membrane resistance, and cell. The prolonged periods ofcolon distension resulted in a tachyphylax- different neurotransmitters on a single ganglion is of the depolarization. -
Selective Serotonin Reuptake Inhibitors, Fluoxetine and Paroxetine, Attenuate the Expression of the Established Behavioral Sensitization Induced by Methamphetamine
Neuropsychopharmacology (2007) 32, 658–664 & 2007 Nature Publishing Group All rights reserved 0893-133X/07 $30.00 www.neuropsychopharmacology.org Selective Serotonin Reuptake Inhibitors, Fluoxetine and Paroxetine, Attenuate the Expression of the Established Behavioral Sensitization Induced by Methamphetamine 1 1 1 1 1 ,1 Yujiro Kaneko , Atsushi Kashiwa , Takashi Ito , Sumikazu Ishii , Asami Umino and Toru Nishikawa* 1 Section of Psychiatry and Behavioral Sciences, Tokyo Medical and Dental University Graduate School, Yushima, Bunkyo-ku, Tokyo, Japan To obtain an insight into the development of a new pharmacotherapy that prevents the treatment-resistant relapse of psychostimulant- induced psychosis and schizophrenia, we have investigated in the mouse the effects of selective serotonin reuptake inhibitors (SSRI), fluoxetine (FLX) and paroxetine (PRX), on the established sensitization induced by methamphetamine (MAP), a model of the relapse of these psychoses, because the modifications of the brain serotonergic transmission have been reported to antagonize the sensitization phenomenon. In agreement with previous reports, repeated MAP treatment (1.0 mg/kg a day, subcutaneously (s.c.)) for 10 days induced a long-lasting enhancement of the increasing effects of a challenge dose of MAP (0.24 mg/kg, s.c.) on motor activity on day 12 or 29 of withdrawal. The daily injection of FLX (10 mg/kg, s.c.) or PRX (8 mg/kg, s.c.) from 12 to 16 days of withdrawal of repeated MAP administration markedly attenuated the ability of the MAP pretreatment to augment the motor responses to the challenge dose of the stimulant 13 days after the SSRI injection. The repeated treatment with FLX or PRX alone failed to affect the motor stimulation following the challenge of saline and MAP 13 days later. -
Neural Plasticity in the Brain During Neuropathic Pain
biomedicines Review Neural Plasticity in the Brain during Neuropathic Pain Myeong Seong Bak 1, Haney Park 1 and Sun Kwang Kim 1,2,* 1 Department of Science in Korean Medicine, Graduate School, Kyung Hee University, Seoul 02447, Korea; [email protected] (M.S.B.); [email protected] (H.P.) 2 Department of Physiology, College of Korean Medicine, Kyung Hee University, Seoul 02447, Korea * Correspondence: [email protected]; Tel.: +82-2-961-0491 Abstract: Neuropathic pain is an intractable chronic pain, caused by damage to the somatosensory nervous system. To date, treatment for neuropathic pain has limited effects. For the development of efficient therapeutic methods, it is essential to fully understand the pathological mechanisms of neuropathic pain. Besides abnormal sensitization in the periphery and spinal cord, accumulating evidence suggests that neural plasticity in the brain is also critical for the development and mainte- nance of this pain. Recent technological advances in the measurement and manipulation of neuronal activity allow us to understand maladaptive plastic changes in the brain during neuropathic pain more precisely and modulate brain activity to reverse pain states at the preclinical and clinical levels. In this review paper, we discuss the current understanding of pathological neural plasticity in the four pain-related brain areas: the primary somatosensory cortex, the anterior cingulate cortex, the periaqueductal gray, and the basal ganglia. We also discuss potential treatments for neuropathic pain based on the modulation of neural plasticity in these brain areas. Keywords: neuropathic pain; neural plasticity; primary somatosensory cortex; anterior cingulate cortex; periaqueductal grey; basal ganglia Citation: Bak, M.S.; Park, H.; Kim, S.K. -
Nervous Tissue
Nervous Tissue • Controls and integrates all body activities within limits that maintain life • Three basic functions – sensing changes with sensory receptors • fullness of stomach or sun on your face – interpreting and remembering those changes – reacting to those changes with effectors • muscular contractions • glandular secretions 12-1 Major Structures of the Nervous System • Brain, cranial nerves, spinal cord, spinal nerves, ganglia, enteric plexuses and sensory receptors 12-2 Organization of the Nervous System • CNS is brain and spinal cord • PNS is everything else 12-3 Nervous System Divisions • Central nervous system (CNS) – consists of the brain and spinal cord • Peripheral nervous system (PNS) – consists of cranial and spinal nerves that contain both sensory and motor fibers – connects CNS to muscles, glands & all sensory receptors 12-4 Subdivisions of the PNS • Somatic (voluntary) nervous system (SNS) – neurons from cutaneous and special sensory receptors to the CNS – motor neurons to skeletal muscle tissue • Autonomic (involuntary) nervous systems – sensory neurons from visceral organs to CNS – motor neurons to smooth & cardiac muscle and glands • sympathetic division (speeds up heart rate) • parasympathetic division (slow down heart rate) • Enteric nervous system (ENS) – involuntary sensory & motor neurons control GI tract – neurons function independently of ANS & CNS 12-5 Neurons • Functional unit of nervous system • Have capacity to produce action potentials – electrical excitability • Cell body • Cell processes = dendrites -
Bi 360 Week 4 Discussion Questions: Electrical and Chemical Synapses
Bi 360 Week 4 Discussion Questions: Electrical and Chemical Synapses 1a) What is the difference between a non-rectifying electrical synapse and a rectifying electrical synapse? A non-rectifying electrical synapse allows information to flow between two cells in either direction (presynaptic cell postsynaptic cell and postsynaptic cell presynaptic cell). A rectifying electrical synapse allows information to flow in only one direction; positive current will flow in one direction which is equivalent to negative current flowing in the opposite direction. 1b) You are conducting a voltage clamp experiment to determine the properties of a synapse within the central nervous system. You conduct the experiment as follows: 1) You depolarize the presynaptic cell and record the voltage in both the pre- and the postsynaptic cell. 2) You hyperpolarize the presynaptic cell and record from the pre- and postsynaptic cell. 3) You depolarize the postsynaptic cell and record from the pre- and postsynaptic cell. 4) You hyperpolarize the postsynaptic cell and record from the pre- and postsynaptic cell. Analyze each piece of data shown below and determine what kind of synapse this is. How did you draw your conclusion? This is a rectifying electrical synapse. When you depolarize the presynaptic cell, there is a response in both the pre and post synaptic cell. When the postsynaptic cell is depolarized, however, there is a depolarization in the postsynaptic cell but no response in the presynaptic cell. A similar trend can be seen in the hyperpolarizing data but in the opposite direction. This means there must be a voltage dependent gate allowing positive current to flow in one direction while preventing it from flowing in the other. -
Regulation of Neuronal Communication by G Protein-Coupled Receptors ⇑ Yunhong Huang, Amantha Thathiah
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector FEBS Letters 589 (2015) 1607–1619 journal homepage: www.FEBSLetters.org Review Regulation of neuronal communication by G protein-coupled receptors ⇑ Yunhong Huang, Amantha Thathiah VIB Center for the Biology of Disease, Leuven, Belgium Center for Human Genetics (CME) and Leuven Institute for Neurodegenerative Diseases (LIND), University of Leuven (KUL), Leuven, Belgium article info abstract Article history: Neuronal communication plays an essential role in the propagation of information in the brain and Received 31 March 2015 requires a precisely orchestrated connectivity between neurons. Synaptic transmission is the mech- Revised 5 May 2015 anism through which neurons communicate with each other. It is a strictly regulated process which Accepted 5 May 2015 involves membrane depolarization, the cellular exocytosis machinery, neurotransmitter release Available online 14 May 2015 from synaptic vesicles into the synaptic cleft, and the interaction between ion channels, G Edited by Wilhelm Just protein-coupled receptors (GPCRs), and downstream effector molecules. The focus of this review is to explore the role of GPCRs and G protein-signaling in neurotransmission, to highlight the func- tion of GPCRs, which are localized in both presynaptic and postsynaptic membrane terminals, in reg- Keywords: G protein-coupled receptors ulation of intrasynaptic and intersynaptic communication, and to discuss the involvement of G-proteins astrocytic GPCRs in the regulation of neuronal communication. Neuronal communication Ó 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved. Synaptic transmission Signaling Astrocytes Neurons Autoreceptors Neurotransmitters 1. -
Understanding the Structure-Function Relationships Between Monoamine Neurotransmitter Transporters and Their Cognate Ions and Ligands
University of North Dakota UND Scholarly Commons Theses and Dissertations Theses, Dissertations, and Senior Projects January 2015 Understanding The trS ucture-Function Relationships Between Monoamine Neurotransmitter Transporters And Their ogC nate Ions And Ligands Bruce Felts Follow this and additional works at: https://commons.und.edu/theses Recommended Citation Felts, Bruce, "Understanding The trS ucture-Function Relationships Between Monoamine Neurotransmitter Transporters And Their Cognate Ions And Ligands" (2015). Theses and Dissertations. 1769. https://commons.und.edu/theses/1769 This Dissertation is brought to you for free and open access by the Theses, Dissertations, and Senior Projects at UND Scholarly Commons. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of UND Scholarly Commons. For more information, please contact [email protected]. UNDERSTANDING THE STRUCTURE-FUNCTION RELATIONSHIPS BETWEEN MONOAMINE NEUROTRANSMITTER TRANSPORTERS AND THEIR COGNATE IONS AND LIGANDS by Bruce F. Felts Bachelor of Science, University of Minnesota 2009 A dissertation Submitted to the Graduate Faculty of the University of North Dakota in partial fulfillment of the requirements for the degree of Doctor of Philosophy Grand Forks, North Dakota August 2015 Copyright 2015 Bruce Felts ii TABLE OF CONTENTS LIST OF FIGURES………………………………………………………………………... xii LIST OF TABLES……………………….………………………………………………… xv ACKNOWLEDGMENTS.…………………………………………………………….… xvi ABSTRACT.………………………………………………………………………….……. xviii CHAPTERS I. INTRODUCTION.………………………………………………………………… 1 The Solute Carrier Super-family of Proteins………………………………. 1 The Neurophysiologic Role of MATs……………………………………... 2 Monoamine Transporter Structure…………………………………………. 5 The Substrate Binding Pocket……………………………………… 10 The S1 binding site in LeuT………………………………... 11 The S1 binding site in MATs………………………………. 13 The S2 binding site in the extracellular vestibule………….. 14 Ion Binding Sites in MATs………………………………………… 17 The Na+ binding sites………………………………………. -
Theories of Depression by Richard H
Theories of Depression by Richard H. Hall, 1998 Monamine/5-HT Hypothesis Just as with schizophrenia, the most popular neurophysiological theory of depression follows from the drugs that are used to treat it. The evolution of antidepressant drugs has, in some ways, been the systematic narrowing down of monoamines to Serotonin. MAO inhibitors are Dopamine-Epinephrine-Norephinephrine-Seratonin agonists. Tricyclic Antidepressants are Norepinephrine-Serotonin agonists, and, finally SSRIs act as Serotonin (5-HT) agonists. Thus, the monoamine hypothesis has evolved in the same way, so that today one popular theory of depression, the Monoamine Hypothesis, is that depression is the result of underactivity of monoamines, especially 5-HT. Besides the fact that antidepression drugs are all monoamine agonists, there is other evidence that supports the theory. First, Reserpine, a monoamine antagonist, which was used to treat things like high blood pressure, is rarely used at the present time due to the fact that depression is a common side effect. Thus, not only can monoamine agonists decrease depression, but monoamine antagonists (Reserpine) can induce depression. Another piece of evidence in support of the Monoamine Hypothesis is that levels of 5-HT, as measured by its metabolites, seem to be correlated with depression. For example, patients who have low levels of a 5-HT metabolite were found to be more likely to have committed suicide. It often takes two to three weeks for antidepressant drugs to effectively treat depression. This is a difficult phenomenon to explain within the context of the monoamine hypothesis. Presumably, in response to monoamine agonists these neurotransmitter levels increase right away, and, if depression is caused by low levels of the neurotransmitter, then depression should decrease as the levels of monoamines increase.